新聞
閱讀標示來源的金融市場、總體經濟、加密貨幣與區塊鏈報導。
Bitcoin price dips under $75K as crypto markets miss tech-stock rebound
BTC price action stayed weak after US nonfarm payrolls data significantly beat forecasts, increasing bets of a December interest-rate hike.
暫時無法翻譯,請重試。
U.S. prediction markets regulator issues demand that clashes directly with courts
The Commodity Futures Trading Commission said regulated exchanges can't cut off customers state-by-state, but firms like Kalshi are under court orders to do so.
暫時無法翻譯,請重試。
Bitcoin miner IREN’s AI revenue milestone slips into 2027 as expansion seeks $6 billion
Conditional funding covers IREN’s initial 0.3GW AI program, while wider FY27 expansion still targets $6 billion of additional financing. Read the full story on CryptoSlate Understand the crypto stories that matter and what to watch next. Get The Catalyst in your inbox
暫時無法翻譯,請重試。
Financial Services Roundup: Market Talk
Find insight on Ayden, European insurers, U.K. banks and more in the latest Market Talks covering Financial Services.
暫時無法翻譯,請重試。
Why is CG Oncology stock surging today?
暫時無法翻譯,請重試。
US warns China it must ‘immediately’ meet terms of Busan trade deal
Washington says Beijing is not fulfilling commitments to increase supply of rare earths and other critical products
暫時無法翻譯,請重試。
The S&P 500 could be dangerously exposed to AI. Here are some simple alternatives.
The large-cap index is nowhere near as diversified as you think.
暫時無法翻譯,請重試。
Why is Globus Medical stock plunging today?
暫時無法翻譯,請重試。
Why is Revolution Medicines stock surging today?
暫時無法翻譯,請重試。
The AI ‘credit card’ is getting costlier as CoreWeave bond yield tops 16%
Coreweave's steep yields reflect stress in the AI debt markets as investors worry about a data center slowdown. What comes next.
暫時無法翻譯,請重試。
AI stocks climb after trillions wiped from market values
Investors had been selling off tech shares in part due to concerns the Democrat election victory would mean slower AI development.
暫時無法翻譯,請重試。
This pharmaceutical ETF is outperforming. Why it could keep climbing
The Invesco Pharmaceuticals ETF continues to outperform as other areas of the market weaken, making it an investment opportunity worth watching.
暫時無法翻譯,請重試。